. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: AIDS Behav. 2013 Nov;17(9):10.1007/s10461-012-0368-x. doi: 10.1007/s10461-012-0368-x

Table 3a.

Age and sex specific HIV prevalence for Vulindlela (N=364).

	Males (%)	95%CI^a	Females (%)	95%CI^a
Under 20 years	0/52 (0)	0, 6.9	9/92(9.8)	4.6, 17.8
20–24	6/42(14.3)	5.4, 28.5	4/27(14.8)	4.2, 33.7
25–29	8/24(33.3)	15.6, 55.3	7/15(46.7)	21.3, 73.4
30–34	1/9(11.1)	0.3, 48.3	3/13(23.1)	5.0, 53.8
35–39	7/11(63.6)	30.8, 89.1	5/9(55.6)	21.2, 86.3
40–44	3/8 (37.5)	8.5, 75.5	1/11(9.1)	0.2, 41.3
45 and above	4/28(14.3)	4.0, 32.7	2/23(8.7)	1.1, 28.0
Total	29/174		31/190

Overall Vulindlela Prevalence (95% CI)	16.7 (11.5, 23.1)		16.3 (11.4, 22.4)

Binomial Confidence Intervals using the Clopper Pearson method